Hambrecht & Quist Capital Management as of June 30, 2011
Portfolio Holdings for Hambrecht & Quist Capital Management
Hambrecht & Quist Capital Management holds 74 positions in its portfolio as reported in the June 2011 quarterly 13F filing
Company (Ticker) |
Portfolio Weight |
Valued At |
Change in Shares |
Share Count |
Share Price |
---|---|---|---|---|---|
WellPoint | 3.8 | $20M | 257k | 78.77 | |
Gilead Sciences (GILD) | 3.8 | $20M | 481k | 41.41 | |
Celgene Corporation | 3.0 | $16M | 264k | 60.32 | |
Aetna | 3.0 | $16M | 360k | 44.09 | |
Mylan | 2.8 | $15M | 605k | 24.67 | |
Dendreon Corporation | 2.8 | $15M | 373k | 39.44 | |
Amgen (AMGN) | 2.8 | $15M | 250k | 58.35 | |
Teva Pharmaceutical Industries (TEVA) | 2.7 | $14M | 295k | 48.22 | |
Perrigo Company | 2.7 | $14M | 163k | 87.87 | |
Cubist Pharmaceuticals | 2.6 | $14M | 385k | 35.99 | |
Vertex Pharmaceuticals Incorporated (VRTX) | 2.5 | $14M | 260k | 51.99 | |
Elan Corporation | 2.5 | $13M | 1.2M | 11.37 | |
Warner Chilcott Plc - | 2.5 | $13M | 540k | 24.13 | |
Amarin Corporation (AMRN) | 2.4 | $13M | 890k | 14.47 | |
Illumina (ILMN) | 2.3 | $12M | 164k | 75.15 | |
Shire | 2.3 | $12M | 127k | 94.21 | |
PerkinElmer (RVTY) | 2.2 | $12M | 431k | 26.91 | |
Akorn | 2.1 | $11M | 1.6M | 7.00 | |
Laboratory Corp. of America Holdings | 2.1 | $11M | 116k | 96.79 | |
Human Genome Sciences | 1.9 | $10M | 413k | 24.54 | |
Life Technologies | 1.9 | $10M | 194k | 52.07 | |
Forest Laboratories | 1.9 | $10M | 254k | 39.34 | |
Baxter International (BAX) | 1.8 | $9.3M | 156k | 59.69 | |
CVS Caremark Corporation (CVS) | 1.7 | $9.1M | 242k | 37.58 | |
Neurocrine Biosciences (NBIX) | 1.7 | $9.0M | 1.1M | 8.05 | |
Alkermes | 1.7 | $8.9M | 479k | 18.60 | |
Alexion Pharmaceuticals | 1.7 | $8.8M | 187k | 47.03 | |
Pharmasset | 1.6 | $8.5M | 76k | 112.20 | |
Kinetic Concepts | 1.6 | $8.3M | 145k | 57.63 | |
Inhibitex | 1.5 | $8.2M | 2.1M | 3.92 | |
Salix Pharmaceuticals | 1.5 | $8.0M | 200k | 39.83 | |
United Therapeutics Corporation (UTHR) | 1.5 | $7.9M | 144k | 55.10 | |
Medco Health Solutions | 1.4 | $7.6M | 134k | 56.52 | |
IDEXX Laboratories (IDXX) | 1.4 | $7.4M | 95k | 77.57 | |
McKesson Corporation (MCK) | 1.4 | $7.1M | 85k | 83.65 | |
Incyte Corporation (INCY) | 1.3 | $7.1M | 373k | 18.94 | |
iShares NASDAQ Biotechnology Index (IBB) | 1.3 | $6.9M | 64k | 106.66 | |
Intellipharmaceuticsintl Inc C | 1.2 | $6.2M | 1.6M | 3.98 | |
Seattle Genetics | 1.1 | $5.8M | 282k | 20.52 | |
Allergan | 1.1 | $5.8M | 69k | 83.25 | |
Express Scripts | 1.1 | $5.8M | 107k | 53.98 | |
Zimmer Holdings (ZBH) | 1.1 | $5.6M | 89k | 63.20 | |
Quest Diagnostics Incorporated (DGX) | 1.0 | $5.3M | 90k | 59.10 | |
Covidien | 1.0 | $5.1M | 97k | 53.23 | |
PAREXEL International Corporation | 0.9 | $4.9M | 208k | 23.56 | |
Thermo Fisher Scientific (TMO) | 0.9 | $4.6M | 72k | 64.39 | |
Merck & Co (MRK) | 0.7 | $3.8M | 107k | 35.29 | |
Acorda Therapeutics | 0.7 | $3.6M | 113k | 32.31 | |
Hologic (HOLX) | 0.6 | $3.2M | 160k | 20.17 | |
Medtronic | 0.6 | $3.0M | 78k | 38.54 | |
Santarus | 0.6 | $3.0M | 876k | 3.37 | |
Amylin Pharmaceuticals | 0.6 | $2.9M | 216k | 13.36 | |
Onyx Pharmaceuticals | 0.5 | $2.9M | 81k | 35.30 | |
Auxilium Pharmaceuticals | 0.5 | $2.8M | 144k | 19.60 | |
Impax Laboratories | 0.5 | $2.8M | 130k | 21.79 | |
Affymax (AFFY) | 0.5 | $2.4M | 352k | 6.87 | |
Adolor Corporation (ADLR) | 0.5 | $2.5M | 1.2M | 1.99 | |
Keryx Biopharmaceuticals | 0.5 | $2.4M | 507k | 4.73 | |
Addus Homecare Corp (ADUS) | 0.4 | $2.3M | 432k | 5.43 | |
Boston Scientific Corporation (BSX) | 0.4 | $2.3M | 326k | 6.91 | |
Medivation | 0.4 | $2.2M | 105k | 21.43 | |
Cooper Companies | 0.4 | $2.0M | 26k | 79.22 | |
UnitedHealth (UNH) | 0.3 | $1.9M | 36k | 51.58 | |
Pharmaceutical Product Development | 0.3 | $1.7M | 64k | 26.84 | |
Watson Pharmaceuticals | 0.3 | $1.7M | 25k | 68.71 | |
Danaher Corporation (DHR) | 0.3 | $1.6M | 31k | 53.00 | |
OncoGenex Pharmaceuticals | 0.3 | $1.6M | 93k | 17.02 | |
Cornerstone Therapeutics | 0.3 | $1.6M | 174k | 8.96 | |
Ironwood Pharmaceuticals (IRWD) | 0.3 | $1.4M | 87k | 15.72 | |
Palomar Medical Technologies | 0.2 | $1.3M | 113k | 11.28 | |
Corcept Therapeutics Incorporated (CORT) | 0.2 | $998k | 250k | 3.99 | |
Telik (TELK) | 0.1 | $641k | 821k | 0.78 | |
XenoPort | 0.1 | $402k | 56k | 7.12 | |
Sanofi Aventis Wi Conval Rt | 0.1 | $250k | 104k | 2.41 |